University Hospitals Birmingham NHS Foundation Trust

Chapters

Status Drug name NICE TAs Comments
Status: Green Beclometasone dipropionate

First line

Status: Green Betamethasone eye/ear/nose drops
Status: Green Ephedrine nose drops 0.5% and 1% drops

Short term use only

Status: Green Flucitasone furoate (Avamys)

Approved for use in children and adults. Previous APC decision reviewed in December 2015.

Status: Green Flucitasone propionate and azelastine (Dymista®)

Third line option for adults and children over 12 with moderate to severe allergic rhinitis who have failed ot respond to a steroid nasal spray with the addition of an oral antihistamine. Follow APC treatment algorithm.

Status: Amber Fluticasone propionate nasal drops (Flixonase Nasule)

Specialist recommendation for nasal polyps.

Status: Green Mometasone furoate aqueous nasal spray

High relative cost. Second line.

Status: Green Mupirocin 2% nasal ointment
Status: Green Naseptin nasal cream

Contains arachis (peanut oil)

Status: Green Octenisan nasal gel

Where allergy to Bactroban® exists or there are supply issues with Bactroban®

Status: Red Polyfax nasal ointment
Status: Green Sodium chloride 0.9% nasal drops
Status: Green Xylometazoline 0.1% nasal spray/drops

Short term use only

Building healthier lives
Back to top